Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
Journal of Medicinal Chemistry
|
September 15, 2006
Structurally simple, potent, Plasmodium selective farnesyltransferase inhibitors that arrest the growth of malaria parasites
Matthew P Glenn, Sung-Youn Chang, Carrie Hornéy, et al.
Theranostics
|
July 21, 2020
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer
Alison K Esser, Michael H Ross, Francesca Fontana, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 19, 2025
First-in-class mitogen-activated protein kinase (MAPK) p38α: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing properties
Mohan E Tulapurkar, Kari Ann Shirey, Katerina Lugkey, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 16, 2024
First-in-Class Mitogen-Activated Protein Kinase p38α: MAPK-Activated Protein Kinase-2 (MK2) Dual Signal Modulator with Anti-inflammatory and Endothelial-stabilizing Properties
Mohan E Tulapurkar, Kari Ann Shirey, Katerina N Lugkey, et al.
Blood
|
April 18, 2022
The ERK2-DBP domain opposes pathogenesis of a mouse JAK2V617F-driven myeloproliferative neoplasm
Yong Zhang, Billy Truong, Shawn P Fahl, et al.
Molecular Cancer
|
May 18, 2013
The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak
Xiaobo Cao, Jeremy L Yap, M Karen Newell-Rogers, et al.
Organic & Biomolecular Chemistry
|
April 30, 2013
Structural modifications of (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione that improve selectivity for inhibiting the proliferation of melanoma cells containing active ERK signaling
Kwan-Young Jung, Ramin Samadani, Jay Chauhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 23, 2020
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
Francesca Fontana, Michael J Scott, John S Allen, et al.
European Journal of Medicinal Chemistry
|
March 18, 2016
Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoprotein
Maryanna E Lanning, Wenbo Yu, Jeremy L Yap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2006
Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5
Charles L Loprinzi, John W Kugler, Debra L Barton, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
Journal of Medicinal Chemistry
|
September 15, 2006
Structurally simple, potent, Plasmodium selective farnesyltransferase inhibitors that arrest the growth of malaria parasites
Matthew P Glenn, Sung-Youn Chang, Carrie Hornéy, et al.
Theranostics
|
July 21, 2020
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer
Alison K Esser, Michael H Ross, Francesca Fontana, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 19, 2025
First-in-class mitogen-activated protein kinase (MAPK) p38α: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing properties
Mohan E Tulapurkar, Kari Ann Shirey, Katerina Lugkey, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 16, 2024
First-in-Class Mitogen-Activated Protein Kinase p38α: MAPK-Activated Protein Kinase-2 (MK2) Dual Signal Modulator with Anti-inflammatory and Endothelial-stabilizing Properties
Mohan E Tulapurkar, Kari Ann Shirey, Katerina N Lugkey, et al.
Blood
|
April 18, 2022
The ERK2-DBP domain opposes pathogenesis of a mouse JAK2V617F-driven myeloproliferative neoplasm
Yong Zhang, Billy Truong, Shawn P Fahl, et al.
Molecular Cancer
|
May 18, 2013
The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak
Xiaobo Cao, Jeremy L Yap, M Karen Newell-Rogers, et al.
Organic & Biomolecular Chemistry
|
April 30, 2013
Structural modifications of (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione that improve selectivity for inhibiting the proliferation of melanoma cells containing active ERK signaling
Kwan-Young Jung, Ramin Samadani, Jay Chauhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 23, 2020
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
Francesca Fontana, Michael J Scott, John S Allen, et al.
European Journal of Medicinal Chemistry
|
March 18, 2016
Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoprotein
Maryanna E Lanning, Wenbo Yu, Jeremy L Yap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2006
Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5
Charles L Loprinzi, John W Kugler, Debra L Barton, et al.
Page
of 12